Author： Gordon Keith Prins Marjanne Schuller Klaus Lewin Joy
Publisher： Reproductive Healthcare Ltd
ISSN： 1472-6483
Source： Reproductive BioMedicine Online, Vol.13, Iss.3, 2006-09, pp. : 313-314
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Ten years have passed since follitropin-beta first became commercially available. It is estimated that more than one million children have been born after ovarian stimulation and/or ovulation induction with this recombinant FSH in assisted reproduction.
Related content
By Chiu Han-Mo Chen Sam Li-Sheng Yen Amy Ming-Fang Chiu Sherry Yueh-Hsia Fann Jean Ching-Yuan Lee Yi-Chia Pan Shin-Liang Wu Ming-Shiang Liao Chao-Sheng Chen Hsiu-Hsi Koong Shin-Lan Chiou Shu-Ti
Cancer, Vol. 121, Iss. 18, 2015-09 ,pp. :
Access to resources
Recommend
Counting the cost of asthma exacerbations
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 345, 2002-01 ,pp. :
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 455, 2004-01 ,pp. :
Inpharma, Vol. 1, Iss. 1441, 2004-01 ,pp. :
Angina Pectoris: Over Six Million Americans Are Affected
Pharmaceutical Innovation, Vol. 11, Iss. 1, 2001-12 ,pp. :